Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.2/5
BioNTech (BNTX US)
Watchlist
43
Analysis
Health Care
•
Germany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cross Asset Strategy
•
21 Dec 2022 02:21
•
Syndicated
CX Daily: What’s in Store for China GDP, Fiscal Policy in 2023
What’s in store for China GDP, fiscal policy in 2023. Hong Kong approval expands mainlanders’ access to mRNA Covid shots. Chinese exporters lose...
Caixin Global
Follow
546 Views
Share
bullish
•
Cross Asset Strategy
•
15 Dec 2022 06:11
•
Syndicated
CX Daily: Chinese Mainlanders Rush to Macao for MRNA Vaccinations
Chinese mainlanders rush to Macao for mRNA vaccinations. Hong Kong readies crypto futures ETFs for retail investors. China calls India border...
Caixin Global
Follow
547 Views
Share
bullish
•
Melco Resorts & Entertainment
•
04 Dec 2022 02:26
•
Syndicated
Weekly Stock Bullfinder - Week of 12/5
As investors we are faced with a deluge of noisy breaking news, business media talking heads, and what has felt like non-stop Fed speakers offering...
Weekly Stock Bull Finder
Follow
528 Views
Share
bearish
•
Pfizer Inc
•
09 Nov 2022 01:02
Pfizer Inc (PFE.US) - What if Pfizer Loses the China Market in the Future?
Pfizer’s China business faces challenges due to VBP/NRDL negotiation and potential further deterioration of Sino-US relations. Together with...
Xinyao (Criss) Wang
Follow
239 Views
Share
bearish
•
SK Bioscience
•
06 Sep 2022 15:15
SK Bioscience (302440 KS): Murky Outlook On Weak Vaccine Demand And Flooding Supply
SK bioscience is a late entrant in the overcrowded COVID-19 vaccine market. Demand for the vaccine is waning globally and is uncertain beyond 2022....
Tina Banerjee
Follow
342 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x